Asia-Pacific
Xtandi Scores Regulatory Win in China for Non-Metastatic Castration-Resistant Prostate Cancer
2020-11-11
Shionogi Accesses Ping An’s Database of 300 Million People in China to Design New Healthcare Services
2020-11-07
Aiming for the First CAR-T Approval in China, JW Therapeutics Debuts on Hong Kong Stock Exchange
2020-11-04
Advance Precision Medicine by Applying Circulating Tumor Cells for Anti-Cancer Drug Screen
2020-10-20Partner
Taiwan’s TTY Biopharm Company Signs COVID-19 Vaccine Deal with BioNTech for 30 Million Doses
2020-10-20
LATEST
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02